synced 9 MIN AGO
01 Record

CVE-2020-16212

Philips Patient Monitoring Devices Exposure of Resource to Wrong Sphere

UnratedPUBLISHEDCNA: icscert
CNA base scoreUnratedNo CNA CVSS vector

02 Description

Philips Patient Monitoring Devices Exposure of Resource to Wrong Sphere

03 Exploitation and scoring

Exploitation
Not assessed. CISA has not published an exploitation assessment for this record, and it is not in the KEV catalog. That is an absence of assessment, not a finding of no risk.
SSVC decision
Not assessed by CISA
EPSS probability
0.37% probability of exploitation activity in the next 30 days.
EPSS percentile
Equal to or higher than the score of 30.7% of scored records. A rank, not a probability.
NVD base score
6.8 (CVSS v3.x), scored by the NVD independently of the CNA.
NVD CVSS vector
CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
NVD analysis status
Modified. NVD last modified this record on 2026-06-17.
Red Hat severity
No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

04 Metadata

Published
2020-09-11 13:13Z6 YR AGO
Last updated
2024-08-04 13:37Z2 YR AGO
Reserved
2020-07-31
Assigning CNA
icscert
Record state
PUBLISHED
Severity
Not rated by the issuing CNA
CNA CVSS vector
Not published by the issuing CNA
Weaknesses
  • CWE-668Exposure of Resource to Wrong SphereClass
Data version
5.1
Document digest
65343581e4056d282dabf3120b73e9bd499ee2768e57de9a732f9b0cd1660da3

05 Affected products

VendorProductVersionsPlatforms
PhilipsPatient Information Center iX (PICiX)B.02, C.02, C.03—

06 References

07 Remediation

Philips released the following versions to remediate reported vulnerabilities: * Patient Information Center iX (PICiX) Version C.03 * Certificate revocation within the system was implemented for PIC iX and Performance Bridge FocalPoint in 2023. The implementation of the IntelliVue Patient Monitors will be completed in Q3 of 2024.